Podcasts about Accreditation

"Any time the patient hears the word 'cancer,' they shut down a little bit, right? They may not hear everything that the oncologist or urologist, or whoever is talking to them about their treatment options, is saying. The oncology nurse is a great person to sit down with the patient and go over the information with them at a level they can understand a little bit more. To go over all the treatment options presented by the physician, and again, make sure that we understand their goals of care," ONS member Clara Beaver, DNP, RN, AOCNS®, ACNS-BC, manager of clinical education and clinical nurse specialist at Karmanos Cancer Institute in Detroit, MI, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about prostate cancer treatment considerations for nurses.  Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by November 21, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the treatment of prostate cancer. Episode Notes  Complete this evaluation for free NCPD. ONS Podcast™ episodes: Episode 387: Prostate Cancer Screening, Early Detection, and Disparities Episode 373: Biomarker Testing in Prostate Cancer Episode 324: Pharmacology 101: LHRH Antagonists and Agonists Episode 321: Pharmacology 101: CYP17 Inhibitors Episode 208: How to Have Fertility Preservation Conversations With Your Patients Episode 194: Sex Is a Component of Patient-Centered Care ONS Voice articles: Communication Models Help Nurses Confidently Address Sexual Concerns in Patients With Cancer Exercise Before ADT Treatment Reduces Rate of Side Effects Frank Conversations Enhance Sexual and Reproductive Health Support During Cancer Nurses Are Key to Patients Navigating Genitourinary Cancers Sexual Considerations for Patients With Cancer The Case of the Genomics-Guided Care for Prostate Cancer ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (Second Edition) Manual for Radiation Oncology Nursing Practice and Education (Fifth Edition) Clinical Journal of Oncology Nursing articles: Brachytherapy: Increased Use in Patients With Intermediate- and High-Risk Prostate Cancers Physical Activity: A Feasibility Study on Exercise in Men Newly Diagnosed With Prostate Cancer The Role of the Advanced Practice Provider in Bone Health Management for the Prostate Cancer Population Oncology Nursing Forum articles: An Exploratory Study of Cognitive Function and Central Adiposity in Men Receiving Androgen Deprivation Therapy for Prostate Cancer ONS Guidelines™ for Cancer Treatment–Related Hot Flashes in Women With Breast Cancer and Men With Prostate Cancer Other ONS resources: Biomarker Database (refine by prostate cancer) Biomarker Testing in Prostate Cancer: The Role of the Oncology Nurse Brachytherapy Huddle Card External Beam Radiation Huddle Card Hormone Therapy Huddle Card Luteinizing Hormone-Releasing Hormone Antagonist Huddle Card Sexuality Huddle Card American Cancer Society prostate cancer page National Comprehensive Cancer Network homepage To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org Highlights From This Episode "I think it's important to note that urologists are usually the ones that are doing the diagnosis of prostate cancer and really start that staging of prostate cancer. And the medical oncologists usually are not consulted until the patient is at a greater stage of prostate cancer. I find that it's important to state because a lot of our patients start with urologists, and by the time they've come to us, they're a lot further staged. But once a prostate cancer has been suspected, the patient needs to be staged for the extent of disease prior to that physician making any treatment recommendations. The staging includes doing a core biopsy of the prostate gland. During this core biopsy, they take multiple different cores at different areas throughout the prostate to really look to see what the cancer looks like." TS 1:46 "[For] the very low- and low-risk group, the most common [treatment] is active surveillance. ... Patients can be offered other options such as radiation therapy or surgery if they're not happy with active surveillance. ... The intermediate-risk group has favorable and unfavorable [status]. So, if they're a favorable, their Gleason score is usually a bit lower, things are not as advanced. These patients are offered active surveillance and then either radical prostatectomy with possible removal of lymph nodes or radiation—external beam or brachytherapy. If a patient has unfavorable intermediate risk, they are offered radical prostatectomy with removal of lymph nodes, external radiation therapy plus hormone therapy, or external radiation with brachytherapy. All three of these are offered to patients, although most frequently we see that our patients are taken in for radical prostatectomy. For the high- or very high-risk [group], patients are offered radiation therapy with hormone therapy, typically for one to three years. And then radical prostatectomy with removal of lymph nodes could also be offered for those patients." TS 7:55 "Radiation can play a role in any risk group depending on the patient's preference. ... The types of radiation that we use are external beam, brachytherapy, which is an internal therapy, and radiopharmaceuticals, [which are] more for advanced cancer, but we are seeing them used in prostate [cancer] as well. External beam radiation focuses on the tumor and any metastasis we may have with the tumor. It can be used in any risk [group] and for recurrence if radiation has not been done previously. If a patient has already been radiated to the pelvic area or to the prostate, radiation is usually not given again because we don't want to damage the patient any further. Brachytherapy is when we put radioactive pellets directly into the prostate. For early-stage prostate cancer, this can be given alone. And for patients who have a higher risk of the cancer growing outside the prostate, it can be given in combination with external beam radiation. It's important to note with brachytherapy, it cannot be used on patients who've had a transurethral resection of the prostate or any urinary problems. And if the patient has a large prostate, they may have to be on some hormone therapy prior to brachytherapy, just to shrink that prostate down a little bit to get the best effect. ... Radiopharmaceuticals treat the prostate-specific membrane antigen." TS 11:05 "The side effects of surgery are usually what deter the patient from wanting surgery. The first one is urinary incontinence. A lot of times, a patient has a lot of urinary incontinence after they have surgery. The other one is erectile dysfunction. A lot of patients may not want to have erectile dysfunction. Or, if having an erection is important to the patient, they may not want to have surgery to damage that. In this day and age, physicians have gotten a lot better at doing nerve-sparing surgeries. And so they really do try to do that so that the patient does not have any issues with erectile dysfunction after surgery. But [depending on] the extent of the cancer where it's growing around those nerves or there are other things going on, they may not be able to save those nerves." TS 15:26 "Luteinizing hormone-releasing hormone, or LHRH antagonists or analogs, lower the amount of testosterone made by the testicles. We're trying to stop those hormones from growing to prevent the cancer. ... When we lower the testosterone very quickly, there can be a lot more side effects. But if we lower it a little bit less, we can maybe help prevent some of them. The side effects are important. When I was writing this up, I was thinking, 'Okay, this is basically what women go through when they go through menopause.' We're decreasing the estrogen. We're now decreasing the testosterone. So, the patients can have reduced or absent sexual desire, they can have gynecomastia, hot flashes, osteopenia, anemia, decreased mental sharpness, loss of muscle mass, weight gain, and fatigue." TS 17:50 "What we all need to remember is that no patient is the same. They may not have the same goals for treatment as the physicians or the nurses want for the patient. We talked about surgery as the most common treatment modality that's presented to patients, but it's not necessarily the option that they want. It's really important for healthcare professionals to understand their biases before talking to the patients and the family. It's also important to remember that not all patients are in heterosexual relationships, so we need to explain recovery after treatment to meet the needs of our patients and their sexual relationships, which is sometimes hard for us. But remembering that—especially gay men—they may not have the same recovery period as a heterosexual male when it comes to sexual relationships. So, making sure that we have those frank conversations with our patients and really check our biases prior to going in and talking with them." TS 27:16

In this episode, Randall Barnes reports on top news stories in HBCU life, including a criminal investigation into Texas Southern University finances by Texas Governor Greg Abbot and Lieutenant Governor Dan Patrick, Tuskegee university's legal fight to maintain accreditation for their College of Veterinary Medicine and the family of slain Albany State volleyball player Mari Creighton recieves a $66.5 million dollar award in their legal case against the Elleven45 nightclub. Prairie View A&M senior Lawryn Radford then gives a special report on a lack of food resources in the Prairie View, Texas area and the contrast with College Station, Texas, the home of Texas A&M University. Later, Randall is joined by Arielle Kilgore to preview the big game between DeSean Jackson's Delaware State Hornets and Chennis Berry's South Carolina State Bulldogs for the MEAC Championship and a trip to the Celebration Bowl. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Dr. Steve Shafer, Editor-in-Chief of the ASA Monitor, visits with Dr. Zach Deutch to discuss the changing landscape of accreditation. Discover how accreditation agencies are evolving, where their authority comes from, how USP 797 impacts anesthesiology, how to best prepare for a visit, and more. Recorded October 2025.

Singapore’s traffic is about to get a little more expensive. From January, ERP rates at four expressway gantries will go up, while six other locations will see temporary reductions over the year-end school holidays. The Land Transport Authority says these changes are aimed at managing congestion where traffic has been building up. But will higher ERP rates really ease the jams, or do drivers just get used to them over time? And are these changes fair to commuters? On The Big Story, Hongbin Jeong speaks to Terence Fan, Assistant Professor of Strategy & Entrepreneurship (Education); Academic Director, Accreditation, Singapore Management University, to find out more.See omnystudio.com/listener for privacy information.

This accredited continuing education program is supported by an educational grant from Sanofi. Credit for the program can be obtained by visiting https://checkrare.com/learning/p-consider-rare-suspecting-and-diagnosing-cidp/ . This program, led by Jeffrey Allen, MD, Professor of Neurology at the University of Minnesota provides an overview on the diagnostic delays that often occur in patients with CIDP as well as best practices to suspect and diagnose this rare condition more efficiently. This activity has been designed to meet the educational needs of physicians specializing in family medicine, pediatrics, and neurology. Other members of the care team may also participate.Learning ObjectivesAfter participating in the activity, learners should be better able to:Describe the early symptoms of CIDP.List best practices which can be used to diagnose CIDP more efficiently.Faculty Jeffrey Allen, MDProfessor of NeurologyDepartment of NeurologyDivision of Neuromuscular MedicineUniversity of MinnesotaMinneapolis, MNDisclosure StatementAccording to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated.Disclosure of relevant financial relationships are as follows:Faculty Educator/PlannerDr. Scott discloses Consultant/Educational talks: Annexon, Alexion, Amgen, CSL Behring, Takeda,BioCryst, Grifols, Argenx, Sanofi, Immunovant, ImmunoAbs, Octapharma, Alnylam, AstraZeneca, Dianthus, Johnson & Johnson, Laboratoire Français du Fractionnement et des Biotechnologies, Nuvig, Akcea Therapeutics, ImmunoPharma,Pfizer.Community Faculty/Patient (Christine Eleeson): No relevant financial relationships with any ineligible companies.Other Planners for this activity have no relevant financial relationships with any ineligible companies.This activity will review off-label or investigational information.The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or CheckRare CE. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.Accreditation and Credit DesignationIn support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and CheckRare CE. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.PhysiciansAmerican Academy of CME, Inc., designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other HCPsOther members of the care team will receive a certificate of participation.There are no fees to participate in the activity.  Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME credit for your participation, please complete the pre-and post-program assessments. Your certificate will be emailed to you within 30 days.PrivacyFor more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm  For more information about CheckRare's privacy policy, please access https://checkrare.com/privacy/ContactFor any questions, please contact: CEServices@academycme.orgCopyright© 2025. This CME-certified activity is held as copyrighted © by American Academy of CME and CheckRare CE. Through this notice, the Academy and CheckRare CE grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

ACTA's Kyle Beltramini welcomes David Eubanks, assistant vice president of the Office of Institutional Assessment and Research at Furman University. Professor Eubanks is an expert on the philosophy and practice of leadership in higher education, particularly learning outcomes assessments, strategic planning, and institutional effectiveness. His work emphasizes using data-driven processes to inform decision-making. He recently completed a term on the National Advisory Committee on Institutional Quality and Integrity (NACIQI). Professor Eubanks and Mr. Beltramini discuss accreditation's essential role in assuring academic quality, how the system has degraded over time, and how it can be effectively reformed.

This episode—recorded live at Becker's 31st Annual The Business and Operations of ASCs event—features Dr. Ken Grubbs, Executive Vice President, Accreditation and Certification Operations, and Chief Nursing Officer, Joint Commission. He discusses how Accreditation 360 is shaping the future of healthcare quality, reducing administrative burden, and promoting collaboration to improve patient outcomes. This episode is sponsored by Joint Commission.

Accreditation trends and expectations are shifting under rising accountability pressures, financial constraints, and increased scrutiny of student outcomes. This episode of the Changing Higher Ed® podcast features Maria Toyoda, President and CEO of the WASC Senior College and University Commission (WSCUC), in a strategic conversation with Dr. Drumm McNaughton about how institutions can strengthen accreditation readiness and support stronger student success. This episode is essential for presidents, provosts, trustees, and senior leaders responsible for accreditation, mission alignment, evidence systems, governance oversight, and long-term institutional resilience. Topics Covered How WSCUC evaluates institutional effectiveness, learning outcomes, and mission alignment The post-pandemic readiness gaps shaping student progression and support needs Program-level earnings, debt, default rates, and transparency expectations How institutional evidence must reflect the students served Financial pressures affecting academic quality, resource planning, and program viability Expectations for continuous improvement and documented assessment cycles The role of governance in sustaining accreditation and institutional credibility Real-World Examples Discussed The Key Indicator Dashboard and how program-level data informs institutional planning Program earnings and debt trends affecting default risk after the repayment restart How military-connected learner documentation informs competency evaluation Institutions balancing support structures with financial pressures and staffing constraints Mission drift and its impact on planning, budgeting, and academic decision pathways Three Key Takeaways for Higher Ed Leaders Institutions must understand their students clearly and align academic design, support systems, and assessment with documented learning needs. Program-level debt, earnings, and completion patterns should drive decisions about program viability, financial planning, and long-term strategy. Continuous improvement requires evidence-based action; leaders must ensure that learning assessment results lead directly to curricular and support refinements. Read the transcript or the extended show summary: https://changinghighered.com/how-wasc-is-shaping-the-future-of-accreditation-and-student-success/   #HigherEdLeadership #Accreditation #WSCUC

In this episode of IDD Health Matters, Dr. Craig Escudé interviews Mary Kay Rizzolo, CEO of the Council on Quality and Leadership (CQL), an international accreditation body focused on improving services for individuals with intellectual and developmental disabilities (IDD). Mary Kay discusses CQL's mission to enhance quality of life through person-centered practices, training, research, and accreditation. She emphasizes the importance of understanding individuals' preferred outcomes, using tools like Personal Outcome Measures, and adopting a strengths-based approach called Appreciative Inquiry. The conversation highlights how treating staff well and respecting the dignity and rights of individuals leads to better health outcomes and reduced emergency interventions. Mary Kay also shares insights from her career and the value of community-based services, concluding with three key recommendations: embrace strengths-based models, tailor supports to individual goals, and presume competence while encouraging risk-taking.

Have you ever felt drawn to help others navigate the unique challenges and strengths that come with ADHD, yet wondered what it truly takes to call yourself an ADHD coach? In this episode, we explore one of the questions we're asked most often; How to become an ADHD coach. As more people receive ADHD diagnoses, many coaches are curious about how they can ethically and effectively support this community. Through our discussion, we share insights from our experience as accredited training providers and as coaches who work extensively in the neurodivergent space. We begin by unpacking the difference between being a coach who works with clients who have ADHD and being an ADHD specialist coach. That distinction matters, because it shapes how you present yourself in the market and the depth of knowledge you need to support clients responsibly. We discuss why true ADHD coaching requires more than a quick online certificate. Coaching neurodivergent clients demands strong foundational coaching skills and a deep understanding of neurodivergence, trauma, and inclusivity. Ethical practice starts with accreditation, understanding professional standards, codes of conduct, and trauma-informed approaches. We also reflect on the importance of seeing clients as whole people, not as a label or diagnosis. While ADHD may influence how someone experiences the world, it doesn't define them. In every coaching conversation, we meet individuals with careers, relationships, goals, and emotions that extend far beyond their diagnosis. A powerful part of our conversation focuses on lived experience. Many aspiring ADHD coaches are themselves neurodivergent, which brings empathy and connection, but it can also blur professional boundaries. We explore how to honour that lived experience without projecting it onto clients and how supervision and reflective practice protect both coach and client. As we close, we talk about the routes available for coaches who want to deepen their expertise, from our Level 7 Coaching Qualification to our Neurodivergent Inclusive Coaching Essentials and full Neurodivergent Inclusive Coaching Programme. Whether you're starting your coaching journey or looking to specialise, this episode offers a grounded view of what ethical, inclusive ADHD coaching looks like in practice.   Timestamps: 00:48 – The difference between an ADHD coach and a coach working with ADHD clients 02:35 – Understanding co-occurring conditions and the importance of inclusivity 04:29 – Why short ADHD coach training courses can be misleading 05:47 – Seeing the whole person, not just the diagnosis 09:55 – Accreditation, CPD and what ethical practice looks like 12:02 – The role of lived experience in building trust and navigating boundaries 14:20 – How neurodivergence changes the way we interpret client behaviour 15:34 – Recognising gaps in your knowledge and choosing the right training 16:59 – Celebrating the growing demand for inclusive coaching   Key Lessons Learned: Ethical ADHD coaching begins with strong, accredited foundational coaching skills. ADHD rarely exists in isolation; understanding co-occurring conditions is vital. Lived experience can build trust, but reflection and supervision protect the coaching relationship. Trauma-informed and inclusive practice are essential for supporting neurodivergent clients. True specialism requires depth, time, and commitment, not a quick online course. Clients want coaches who understand their individuality, not their label. Accreditation demonstrates professionalism and builds client confidence. Continuous professional development ensures you evolve with the growing field of neurodiversity. Inclusive language and awareness create safer, more empowering coaching spaces. The future of coaching lies in understanding and celebrating neurodiversity, not reducing it to a niche.   Keywords: ADHD coach, ADHD coaching training, neurodivergent inclusive coaching, ICF accredited coaching, ethical coaching, trauma-informed coaching, neurodiversity in coaching, ADHD coaching certification UK, inclusive coaching practice, professional coach accreditation,   Links & Resources: igcompany.com/ndessentials igcompany.com

Behind the Screen: The Impact of AI Companions on Adolescents Evaluation and Credit:  https://www.surveymonkey.com/r/medchat84 Target Audience This activity is targeted toward primary care physicians and advanced providers. Statement of Need This will be a two-part podcast that will focus on the psychological effects of cyberbullying and AI companions. This will be specific to adolescents and teens. As a result of the growing prevalence in digital engagement, a by-product has been cyberbullying. The psychological effects of cyberbullying are unique in that they differ from traditional bullying due to the anonymity and permanence. Additionally, with the growing popularity of AI companions a second podcast will address this topic. Both podcasts will address the psychological effects and provide tools for providers to use to screen for subtle signs as well as resources. Objectives Define what constitutes an AI companion and differentiate from interactive AI-enabled toys. Discuss how frequent interaction with AI companions can influence psychological and social development of adolescents and teens. Identify behavioral and psychological signs that may indicate an adolescent/teen has or is developing an unhealthy reliance on AI companions. Moderator Mark McDonald, M.D., MHA, CPE System Vice President Pediatric Medical Affairs Norton Healthcare Medical Director, Norton Children's Professor, University of Louisville School of Medicine Department of Pediatrics Division of Pediatric Critical Care Speaker Michael Eiden, Ph.D, LCSW, LCADC, CSAT, CCSMichael Eiden, PhD, LCSW, LCADC, CSAT, CCS Licensed Clinical Social Worker Licensed Clinical Alcohol and Drug Counselor Certified Sex Addiction Therapist Certified Clinical Supervisor Board Certified Sex Therapist EMDR Trained Eiden Integrative Counseling Planner and Moderator Disclosures  The planners, moderator and speaker of this activity do not have any relevant financial relationships with ineligible companies to disclose. Commercial Support  There was no commercial support for this activity.  GrantThis episode is supported by a grant from the Kentucky Medical Association's 'Small STEPS, Big Impact' campaign, a two-year initiative that encourages patients to achieve long-term success through taking simple steps that can add up to make a big impact on their health. The campaign focuses on five key areas (screenings, tobacco use, exercise & nutrition, physician visits and stress) and offers straightforward strategies and support for patients. It is a partnership between the KMA and its charitable arm, the Kentucky Foundation for Medical, made possible by a grant from the Kentucky Department for Public Health. For more information, visit SmallSTEPSKy.org.   Physician Credits Accreditation Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians. Designation Norton Healthcare designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nursing CreditsNorton Healthcare Institute for Education and Development is approved as a provider of nursing continuing professional development by the South Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This continuing professional development activity has been approved for 0.50 ANCC CE contact hours. In order for nursing participants to obtain credits, they must claim attendance by attesting to the number of hours in attendance.   For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or sally.sturgeon@nortonhealthcare.org. Social Worker CreditsThis activity will provide .50 hours of required continuing education units. National Association of Social Workers, Kentucky Chapter (NASW-KY) is an approved provider for social work credits through the Kentucky Board of Social Work. NASWKY#06/30/25. For information about social worker credits, please send an email to cme@nortonhealthcare.org. Resources for Additional Study/References Internet Addiction Assessment (IAA) https://psychology-tools.com/test/internet-addiction-assessment Parent Tools – Operation Parent https://www.operationparent.org/ Parent Tools – Children and Screens https://www.childrenandscreens.org/ Digital companionship or psychological risk? The role of AI characters in shaping youth mental health https://pubmed.ncbi.nlm.nih.gov/39798495/ Artificial Intelligence and Adolescent Well-being https://www.apa.org/topics/artificial-intelligence-machine-learning/health-advisory-ai-adolescent-well-being SmallSTEPSKy.org   Date of Original Release | Nov. 2025; Information is current as of the time of recording. Course Termination Date | Nov. 2027 Contact Information | Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org   Also listen to Norton Healthcare's podcast Stronger After Stroke. This podcast, produced by the Norton Neuroscience Institute, discusses difficult topics, answers frequently asked questions and provides survivor stories that provide hope. Norton Healthcare, a not for profit health care system, is a leader in serving adult and pediatric patients throughout Greater Louisville, Southern Indiana, the commonwealth of Kentucky and beyond. More information about Norton Healthcare is available at NortonHealthcare.com.

Accreditation 360 is coming January 1, 2026, and hospitals are asking the same questions: What changes matter most, and what are surveyors actually citing?In this episode of Healthcare Facilities Network, Steve Van Ness, Vice President of Planning and Design at CREF, and Thomas Grice, Vice President of Corporate Real Estate and Facilities at CREF, share field insights you won't get anywhere else. They break down the top life safety findings hospitals are seeing, highlight common pitfalls, and offer practical strategies to help teams prepare for the new standards.Whether you manage facilities, compliance, or hospital operations, this episode gives you an actionable view of what matters most. If you want the insider perspective on Accreditation 360 before it hits, this is the conversation you can't afford to miss.

This episode's a little different. Instead of me asking the questions, I'm the one being interviewed. Highly Accomplished teacher Andrew Cornwall and I sit down to talk about teaching, accreditation, and what it means for all of us to be expert practitioners. We dig into how great teaching grows through shared practice, honest reflection, and the everyday work we do alongside our colleagues. It's a relaxed, thoughtful chat about the craft of teaching, the challenges of accreditation, and why supporting each other as professionals matters more than ever.

Today's podcast features an interview with Dr. Kevin Biese, Chair of the Board of the American College of Emergency Physicians Geriatric Emergency Accreditation program, and Dr. Natalie Elder, Director of Geriatric Emergency Medicine for the Vermont Health Network. We learn about the Geriatric Emergency Department Certification program, and how it provides a roadmap for organizing and care for rural geriatric patients. The transcript and a list of resources and organizations mentioned in the episode can be found at: https://www.ruralhealthinfo.org/podcast/geriatric-ed-nov-2025 Exploring Rural Health is an RHIhub podcast.

This special episode of the Psychology of Work Podcast marks the 25th anniversary of the ABP, and in it we hear from three distinguished ABP members who have each served as Chair or Vice Chair at different points in the organisation's history. In discussion with Rob Feltham, they reflect on what the ABP has achieved during its first quarter of century and share their aspirations for the ABP's future. Pauline Grant played a key role in the inception of the ABP and became its first Vice Chair. Steve Whiddett served as Chair for four years from 2009. And Claire Lish is the ABP's current Chair.  When founded in 2020, the ABP became a new professional home and voice for Business Psychology, and over the subsequent 25 years the organisation has been instrumental in increasing public awareness and recognition of the profession.  The ABP has developed a distinctive ethos with its focus on: working shoulder-to-shoulder with clients to achieve practical evidence-based solutions; guardianship and growth of the Business Psychology profession; and emphasis on training and education to ensure that Business Psychology becomes steadily more mainstream and integral to the business agenda.  In 2009 the Health & Care Professionals Council (HCPC) was given statutory responsibility for regulating practitioner psychologists, and this was a critical juncture for the ABP.  Given the HCPC's orientation towards healthcare, it was seen by many as lacking relevance and fit for the Business Psychology profession. The ABP was proactive and successful in establishing a separate identity and path for Business Psychology, subsequently reinforcing this with training and accreditation open to those entering the profession by non-traditional as well as traditional routes.  Key trends and changes in Business Psychology over the ABP's first quarter century have included: growing internationalisation and industry consolation, bringing far greater focus on global partnership and appreciation of diverse perspectives; and much greater emphasis on the organisational and social context for individual behaviour.  Whilst much has been achieved by the ABP over 25 years, there is some way to go to ensure that Business Psychology becomes a non-negotiable component of the organisational and business agenda.  The podcast guests  Pauline Grant  Pauline Grant was awarded Honorary Membership of the ABP in recognition of her pivotal role in the organisation's founding and her enduring contribution to the profession. As the ABP's founding Vice Chair, Pauline helped to shape the direction and values of the Association, serving in that role for four formative years. A trusted advisor to C-suite leaders across the globe, Pauline brought authenticity, insight, and unwavering commitment to the application of psychology in improving working lives. Her influence has helped to embed business psychology at the heart of strategic leadership and organisational development.  A Chartered Psychologist and former Director at the boutique consultancy YSC, Pauline's career has spanned high-level consulting, leadership coaching, and talent development. She is known for her humility, intellectual clarity, and sincere focus on helping individuals thrive. She authored Careering Upwards in 2001 and edited two of the ABP's flagship publications – Business Psychology in Practice and Business Psychology in Action – bringing together case studies and practical insights from across the profession. Even in retirement, Pauline continues to support the development of others through pro bono work and community contribution. She has supported The ABP Workforce Experience Awards as a Judge, demonstrating her continued investment in the Association's growth and influence. Pauline's Honorary Membership celebrates not just her professional achievements but her generous spirit, steadfast dedication, and lasting impact on the evolution of business psychology.  Steve Whiddett    Steve Whiddett was awarded Honorary Membership of The ABP in recognition of his outstanding service to the profession and his pivotal role in shaping the Association. A Chartered Psychologist, consultant, and author, Steve has been a leading voice in applying psychology to organisational performance, change, and leadership. As founder of WHE-UK, he championed ethical, human-centred change, and his published works, including The CIPD Competencies Handbook (1999, with Sarah Hollyforde) and A Practical Guide to Competencies (2003), have become standard references in the field. Representing the ABP, he also contributed to the BPS Division of Occupational Psychology's Professional Guidelines for Assessment Centres (2015).  Steve served as Chair of the ABP from 2009 to 2013, a period of transformation in which the Association refined its purpose, values, and governance, introduced professional management services, and laid the foundations for long-term stability. He was instrumental in affirming the ABP's inclusive identity, ensuring it welcomed all who apply psychology in business, and preparing the way for its renaming in 2013 as the Association for Business Psychology. Steve's leadership, clarity of thought, and generosity of spirit continue to inspire the ABP community.  Claire Lish   Claire Lish is an accomplished Chartered HR and Change Management professional, recognised for her expertise in organisational transformation, governance, and people strategy. With over 20 years of leadership experience, she has guided businesses through complex restructures, cultural change, and strategic workforce development, always with a focus on aligning people practices to long-term business success.As current Chair of the Association for Business Psychology, Claire brings her deep commitment to evidence-based practice and inclusive leadership to the ABP community, championing the role of business psychology in improving working lives. Alongside her work with the ABP, she serves as Chair of the People Committee at Hundred Houses Society and leads her own consultancy, Psynergy Consulting, where she advises on retained HR leadership, board effectiveness, and business transformation. A Fellow of the ABP, the Institute of Leadership, and the CIPD, Claire is widely regarded as a transformational HR consultant and award-winning organisational development leader. Her career reflects not only governance acumen and operational insight, but also a genuine passion for shaping workplaces where people and organisations thrive.  Rob Feltham is Podcast Editor for the ABP.

Send us a textCaleb and James explore the Rupicolous Laelias, a group of lithophytic Cattleyas found in South America. With over 60 species described, this group of orchids continues to grow, with two new species described in the last few years.Thanks for listening to The Orchid Pod. Send us an email at theorchidpod@gmail.com or leave us a voicemail/text at +1-678-6ORCHID (+1-678-667-2443 - Standard rates apply).

"[When] a lot of men think about prostate exams, they immediately think of the glove going on the hand of the physician, and they immediately clench. But really try to talk with them and discuss with them what some of the benefits are of understanding early detection. Even just having those conversations with their providers so that they understand what the risk and benefits are of having screening. And then educate patients on what a prostate-specific antigen (PSA) and digital rectal exam (DRE) actually are—how it happens, what it shows, and what the necessary benefits of those are," ONS member Clara Beaver, DNP, RN, AOCNS®, ACNS-BC, manager of clinical education and clinical nurse specialist at Karmanos Cancer Institute in Detroit, MI, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about prostate cancer screening, early detection, and disparities. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.25 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by October 31, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to prostate screening, early detection, and disparities. Episode Notes  Complete this evaluation for free NCPD. ONS Podcast™ Episode 149: Health Disparities and Barriers in Metastatic Castration-Sensitive Prostate Cancer ONS Voice articles: Gender-Affirming Hormones May Lower PSA and Delay Prostate Cancer Diagnosis in Transgender Women Healthy Lifestyles Reduce Prostate Cancer Mortality in Patients With Genetic Risk Hispanic Patients Are at Higher Risk for Aggressive Prostate Cancer but Less Likely to Get Treatment Leveling State-Level Tax Policies May Increase Equality in Cancer Screening and Mortality Rates Most Cancer Screening Guidelines Don't Disclose Potential Harms ONS book: Understanding Genomic and Hereditary Cancer Risk: A Handbook for Oncology Nurses ONS course: Genomic Foundations for Precision Oncology Clinical Journal of Oncology Nursing article: Barriers and Solutions to Cancer Screening in Gender Minority Populations Oncology Nursing Forum articles: Disparities in Cancer Screening in Sexual and Gender Minority Populations: A Secondary Analysis of Behavioral Risk Factor Surveillance System Data Symptom Experiences Among Individuals With Prostate Cancer and Their Partners: Influence of Sociodemographic and Cancer Characteristics Other ONS resources: Genomics and Precision Oncology Learning Library ONS Biomarker Database (refine by prostate cancer) American Cancer Society prostate cancer early detection, diagnosis, and staging page National Institutes of Health prostate cancer screening page U.S. Preventive Services Task Force prostate cancer screening recommendation statement To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org Highlights From This Episode "The recommendations are men [aged] 45 who are at high risk, including African American men and men who have a first-degree relative who has been diagnosed with prostate cancer younger than 65 should go through screening. And men aged 40 at an even higher risk, these are the men that have that one first-degree relative who has had prostate cancer before 65. Screening includes the PSA blood test and a digital exam. Those are the screening recommendations, although they are a little bit controversial." TS 3:42 "You still see PSAs and DREs as the first line because they're easier for primary care providers to perform. ... Those are typically covered by insurance, so they still play that role in screening. But with the advent of MRIs and biomarkers, these have really helped refine that screening process and determine treatment options for our patients. Again, those patients who may be at a bit of a higher risk could go for an MRI or have biomarkers completed. Or if they're on that verge with their Gleason score, instead of doing a biopsy, they may send the patient for an MRI or do biomarkers for that patient. ... These updated technologies put [patients] a little bit more at ease that someone's watching what's going on, and they don't have to have anything invasive done to see where they're at with their staging." TS 4:35 "Disparities in screening access exist based on race, socioeconomic status, gender identity, education, and geography. It's really hard in rural areas to get primary care providers or urologists who can actually see these patients, [and] sometimes in urban areas. So socioeconomic status can affect that, but also where a person lives. African American men with lower incomes and people in rural areas face the greatest barriers to receiving screening. It's also important to encourage anyone with a prostate to be screened and offer gender-neutral settings for patients to feel comfortable." TS 7:50 "I think a lot of men feel like if they have no symptoms, they don't have prostate cancer ... so a lot of patients may put off screening because they feel fine, [they] haven't had any urinary symptoms, it doesn't run in their family. ...With prostate cancer, there usually are not symptoms that a patient's having—they may have some urinary issues or some pain—but it's not very frequent that they have that. So, just making sure our patients understand that even though they're not feeling something, it doesn't mean there's not something else going on there." TS 12:53 "Prostate cancer found at an early age can be very curable, so it's really important for men to have those conversations with their providers about the risk and benefits of screening. And anyone that we can help along the way to be able to have those conversations, I think is a great thing for oncology nurses to do." TS 15:44

This episode—recorded live at Becker's 31st Annual The Business and Operations of ASCs event—features Dr. Ken Grubbs, Executive Vice President, Accreditation and Certification Operations, and Chief Nursing Officer, Joint Commission. He discusses how Accreditation 360 is shaping the future of healthcare quality, reducing administrative burden, and promoting collaboration to improve patient outcomes.This episode is sponsored by Joint Commission.

This episode—recorded live at Becker's 31st Annual The Business and Operations of ASCs event—features Dr. Ken Grubbs, Executive Vice President, Accreditation and Certification Operations, and Chief Nursing Officer, Joint Commission. He discusses how Accreditation 360 is shaping the future of healthcare quality, reducing administrative burden, and promoting collaboration to improve patient outcomes.This episode is sponsored by Joint Commission.

This episode kicks off a series of conversations that originated with the DEI Symposium, held at NCDA's 2025 Global Career Development Conference in Atlanta, Georgia. Dr. Cheryl Love leads a panel discussion of the challenges and strategies for providing career services amid today's social and political turmoil. The panel - including Dr. Natasha Barnes-Gwynn, Dr. Frank Gorritz, and Ruben Britt - shares insights into the impact of the current political and social climate on career development. The discussion emphasizes the importance of wellness, cultural competence, empathy, and advocacy for minoritized communities. The speakers also highlight the role of career counselors as frontline responders, providing not just career advice but also emotional and psychological support to their students and clients. The episode concludes with a call to action for practitioners to join the NCDA's Diversity Initiative and Cultural Inclusion (DICI) committee and contribute to the ongoing movement for social justice and equity in career development.Dr. Cheryl Love is a Career Counselor and a College Specialist for the Arts, Humanities, School of Education and School of Public Policy in the Career Center at the University of California, Riverside. In this role she also serves as the Liaison to the African Student Programs, the Black Student Success Initiative, Basic Needs, UCR Transfer Work Group, and the Kessler Scholar Program. Dr. Natasha Barnes-Gwynn, CCC, NCC, FCD-I is a Clinical Professor at Southern New Hampshire University. She also serves as a career consultant through her private practice, Increasing Our Understanding (I.O.U.) Consultation, LLC. Dr. Barnes-Gwynn is a newly appointed board member for the Council of Accreditation and Related Educational Programs.Dr. Frank Gorritz FitzSimons, LPC, is a counselor educator in Florida. He is a nationally recognized scholar and counselor educator on topics including providing affirmative counseling care to queer and transgender communities of color, providing multicultural supervision, utilizing diverse approaches to counseling work, as well as addressing and disrupting white supremacy in counselor education. Ruben Britt, Jr. is an educator, author, lecturer, and nationally certified career counselor with over 49 years of experience in education as both a teacher and career planning counselor. A nationally recognized expert on career coaching and educational issues, Ruben has served as a consultant for the U.S. Department of Education, the Educational Testing Service, the New Jersey Department of Higher Education, and several colleges and community organizations. ResourcesNCDA's DICI CommitteeDEI Symposium 2026 - Proposal Submissions FormNCDA Social Justice Resources

As we kickoff season 6 of the podcast, we feature co-authors of Foundations of Assessment: From Theory to Practice, a recently released book from Routledge. Our guests are Joe Levy and Natasha Jankowski. Joe is Associate Vice Provost of Accreditation and Quality Improvement at Excelsior University. Natasha is Director of the Center for Excellence in Teaching and Learning at the University of Wisconsin-Milwaukee. Link to resources mentioned in this episode:Foundations of Assessment: From Theory to Practicehttps://www.routledge.com/Foundations-of-Assessment-From-Theory-to-Practice/Levy-Jankowski/p/book/9781032581569  This season of Leading Improvements in Higher Education is sponsored by the Center for Assessment and Research Studies at James Madison University; learn more at jmu.edu/assessment. Episode recorded: September 2025.  Host:  Stephen Hundley.  Producers:  Chad Beckner and Angela Bergman.  Original music:  Caleb Keith.  This award-winning podcast is a service of the Assessment Institute in Indianapolis; learn more go.iu.edu/assessmentinstitute.

Nurses Out Loud with Jodi O'Malley MSN, RN – Unsafe staffing puts patients and nurses at risk — and now, hospitals face real consequences. Beginning in 2026, the Joint Commission's new National Performance Goals require proof of adequate, competent nurse staffing. Facilities that fail to meet safe staffing standards could lose their accreditation and Medicare funding, signaling a major shift toward healthcare accountability...

Nurses Out Loud with Jodi O'Malley MSN, RN – Unsafe staffing puts patients and nurses at risk — and now, hospitals face real consequences. Beginning in 2026, the Joint Commission's new National Performance Goals require proof of adequate, competent nurse staffing. Facilities that fail to meet safe staffing standards could lose their accreditation and Medicare funding, signaling a major shift toward healthcare accountability...

Joint Commission is rolling out Accreditation 360, a major update to hospital standards that takes effect January 1, 2026. In this episode of Healthcare Facilities Network, Jim Grana, Life Safety Code Field Director at Joint Commission, walks us through what these changes mean for hospitals and healthcare teams across the U.S.Jim explains how the standards are being restructured, including a nearly 50% reduction in Elements of Performance for some hospitals, and offers practical guidance on how organizations can prepare. From understanding the new numbering system to identifying what's critical for compliance, this episode makes Accreditation 360 clear and actionable.Whether you're directly involved in hospital compliance or just curious about how these updates impact healthcare operations, Jim provides insight, strategies, and perspective to help teams stay ahead of the changes.

Bill Zimmerman is an assistant teaching professor in the department of advertising and public relations in the Donald P. Bellisario College of Communications at Penn State. He's the author of “Understanding the Creator Economy: Making Digital Media Work for You,” published by Kendall Hunt. He teaches courses such as Digital PR and PR Campaigns, and in the spring semester will offer Digital Content and the Creator Economy, a new course launching Penn State's content creator certificate program. Prior to teaching, he worked as a newspaper reporter and public relations professional in higher education. He also holds the Accreditation in Public Relations.

Australia faces an engineering shortage, yet many migrant engineers are underemployed. Learn about qualification recognition, job search tips, CV advice, and networking strategies. - آسٹریلیا میں انجنیئرز کی کمی کا سامنا ہے، لیکن بہت سے تارکین وطن انجینئر اپنی قابلیت سے کم اہلیت کی ملازمت کر رہے ہیں۔ اپنی قابلیت کی توثیق کے بارے میں معلومات حاصل کریں، ملازمت تلاش کرنے کی تجاویز، سی وی مشورے، اور نیٹ ورکنگ کی حکمت عملیوں کے بارے میں جانیں۔

Australia faces an engineering shortage, yet many migrant engineers are underemployed. Learn about qualification recognition, job search tips, CV advice, and networking strategies. - ஆஸ்திரேலியாவில் பொறியியல் துறையில் பணியாளர் பற்றாக்குறை நிலவுகிறது, ஆனால் பல புலம்பெயர்ந்த பொறியாளர்கள் தகுந்த வேலை வாய்ப்புகளை பெற முடியாமல் உள்ளனர். இந்தப்பின்னணியில் பொறியியல் பணிக்கான தகுதிச் சான்றிதழ் அங்கீகாரம், வேலை தேடல் குறிப்பு, சுயவிவர (CV) ஆலோசனைகள் மற்றும் தொழில்முறை தொடர்புகளை உருவாக்கும் முறைகள் குறித்து அறிந்துகொள்வோம்.

Australia faces an engineering shortage, yet many migrant engineers are underemployed. Learn about qualification recognition, job search tips, CV advice, and networking strategies. - ඕස්ට්‍රේලියාවේ මේ වනවිට ඉංජිනේරු වෘත්තිකයින්ගේ හිඟයකට මුහුණ දී සිටියත්, බොහෝ සංක්‍රමණික ඉංජිනේරුවන් රැකියා විරහිතව සිටින බව වාර්තා වේ. සුදුසුකම් හඳුනා ගැනීම, රැකියා සෙවීමේ උපදෙස්, CV සඳහා වන උපදෙස් සහ networking උපාය මාර්ග ගැන ඉගෙන ගැනීම මේ හේතුවෙන් වැදගත් වේ

Behind the Screen: The Impact of Cyberbullying on Adolescents and Teens Evaluation and Credit:  https://www.surveymonkey.com/r/medchat83 Target Audience             This activity is targeted toward primary care physicians and advanced providers. Statement of NeedThis will be a two-part podcast that will focus on the psychological effects of cyberbullying and AI companions. This will be specific to adolescents and teens. As a result of the growing prevalence in digital engagement, a by-product has been cyberbullying. The psychological effects of cyberbullying are unique in that they differ from traditional bullying due to the anonymity and permanence. Additionally, with the growing popularity of AI companions a second podcast will address this topic. Both podcasts will address the psychological effects and provide tools for providers to use to screen for subtle signs as well as resources. Objectives  Define cyberbullying and distinguish its varying levels of severity. Describe the psychological effects of cyberbullying and differentiate its impact from traditional bullying in pediatric populations. Identify clinical indicators, behavioral signs and psychosocial cues that may suggest that a patient is a victim of cyberbullying. Moderator Mark McDonald, M.D., MHA, CPE System Vice President Pediatric Medical Affairs Norton Healthcare Medical Director, Norton Children's Professor, University of Louisville School of Medicine Department of Pediatrics Division of Pediatric Critical Care SpeakerMichael Eiden, PhD, LCSW, LCADC, CSAT, CCS Licensed Clinical Social Worker Licensed Clinical Alcohol and Drug Counselor Certified Sex Addiction Therapist Certified Clinical Supervisor Board Certified Sex Therapist EMDR Trained Eiden Integrative Counseling   Planner and Moderator Disclosures  The planners, moderator and speaker of this activity do not have any relevant financial relationships with ineligible companies to disclose. Commercial Support There was no commercial support for this activity.  GrantThis episode is supported by a grant from the Kentucky Medical Association's ‘Small STEPS, Big Impact' campaign, a two-year initiative that encourages patients to achieve long-term success through taking simple steps that can add up to make a big impact on their health. The campaign focuses on five key areas (screenings, tobacco use, exercise & nutrition, physician visits and stress) and offers straightforward strategies and support for patients. It is a partnership between the KMA and its charitable arm, the Kentucky Foundation for Medical, made possible by a grant from the Kentucky Department for Public Health. For more information, visit SmallSTEPSKy.org.     Physician Credits Accreditation Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians. Designation Norton Healthcare designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nursing CreditsNorton Healthcare Institute for Education and Development is approved as a provider of nursing continuing professional development by the South Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This continuing professional development activity has been approved for 0.50 ANCC CE contact hours. In order for nursing participants to obtain credits, they must claim attendance by attesting to the number of hours in attendance.     For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or sally.sturgeon@nortonhealthcare.org. Social Worker CreditsThis activity will provide .50 hours of required continuing education units. National Association of Social Workers, Kentucky Chapter (NASW-KY) is an approved provider for social work credits through the Kentucky Board of Social Work. NASWKY#06/30/25. For information about social worker credits, please send an email tocme@nortonhealthcare.org.   Resources for Additional Study/References Internet Addiction Assessment (IAA) https://psychology-tools.com/test/internet-addiction-assessment Parent Tools – Operation Parent https://www.operationparent.org/ Parent Tools – Children and Screens https://www.childrenandscreens.org/ Adverse Childhood Experiences and Early Adolescent Cyberbullying in the United States https://pubmed.ncbi.nlm.nih.gov/36443937/ Social Epidemiology of Early Adolescent Cyberbullying in the United States https://pubmed.ncbi.nlm.nih.gov/35840085/   SmallSTEPSKy.org   Date of Original Release | Oct. 2025; Information is current as of the time of recording.  Course Termination Date | Oct. 2027 Contact Information | Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org   Also listen to Norton Healthcare's podcast Stronger After Stroke. This podcast, produced by the Norton Neuroscience Institute, discusses difficult topics, answers frequently asked questions and provides survivor stories that provide hope. Norton Healthcare, a not for profit health care system, is a leader in serving adult and pediatric patients throughout Greater Louisville, Southern Indiana, the commonwealth of Kentucky and beyond. More information about Norton Healthcare is available at NortonHealthcare.com.

Episode: 00287 Released on October 6, 2025 Description: In this episode of Analyst Talk with Jason Elder, retired Director of State Operations for New York's Crime Analysis Center Network, John Riegert, shares how a handful of analysts grew into a statewide intelligence powerhouse connecting 57 counties. Drawing from 40 years in law enforcement, including his time as a captain with Troy PD, John discusses the evolution of crime analysis in New York from data struggles and building legitimacy to creating analyst certifications, promoting leadership opportunities, and balancing privacy with real-time policing needs. His insights reveal how the profession matured into an essential pillar of modern public safety.

“I think that this is an area that is exploding. Working with drug development, I see new agents all the time, with unique targets I've never heard about, with targets I have heard about used in a different way. So, I really think we're going to see more and more bispecifics. A lot of these drugs are used second line, third line, fourth line. I would not be surprised if they moved up in treatment, especially as we learn safer ways to give these drugs,” ONS member Moe Schwartz, PharmD, BCOP, FHOP, professor of pharmacy practice at the James L. Winkle College of Pharmacy at the University of Cincinnati, OH, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about bispecific antibodies.  Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by October 3, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learner will report an increase in knowledge related to the use of bispecific antibodies in the treatment of cancer. Episode Notes  Complete this evaluation for free NCPD. ONS Podcast™ episodes: Pharmacology 101 series Episode 275: Bispecific Monoclonal Antibodies in Hematologic Cancers and Solid Tumors Episode 261: CAR T-Cell Therapy for Hematologic Malignancies Requires Education and Navigation Episode 176: Oncologic Emergencies: Cytokine Release Syndrome ONS Voice articles: An Oncology Nurse's Guide to Bispecific Antibodies Bispecific Antibodies Cross-Discipline Cancer Care ONS Voice oncology drug reference sheets: Amivantamab-Vmjw Blinatumomab Epcoritamab-Bysp Glofitamab-Gxbm Mosunetuzumab-Axgb Tebentafusp-Tebn Teclistamab-Cqyv ONS book: Guide to Cancer Immunotherapy (second edition) ONS course: ONS/ONCC® Chemotherapy Immunotherapy Certificate™ Clinical Journal of Oncology Nursing article: Optimizing Transitions of Care in Multiple Myeloma Immunotherapy: Nurse Roles Other ONS resources: Bispecific Antibodies Video Bispecifics Huddle Card Cytokine Release Syndrome Huddle Card Immune Effector Cell–Associated Neurotoxicity Syndrome Huddle Card DailyMed homepage Hematology/Oncology Pharmacy Association late-breaking news article: The Emerging Use of Bispecific Antibodies with Chemotherapy in Diffuse Large B-Cell Lymphoma To discuss the information in this episode with other oncology nurses, visit the ONS communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org Highlights From This Episode “It was 2014 that most of us think of as the beginning of bispecifics in cancer, and that was with approval of blinatumomab. That was granted accelerated approval for the treatment of patients with Philadelphia chromosome–negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia. It is a bispecific that targets CD19-expressing tumor cells and CD3 on T cells. It's the original bispecific T-cell engager and is often called a ‘BiTE.'” TS 2:11 “The term ‘bispecific' means that this is an artificial protein that's developed to hit two different antigens simultaneously. They can be two different epitopes on the same antigen. They can be an antigen on a cancer cell and CD3 on a T cell that kind of recruits the T cell to the cancer. So, there are different types [of bispecific antibodies]. The subtype that we often talk about are bispecific T-cell engagers, which are those bispecifics that do target the T cell. And currently, the target on the T cell that's utilized is the CD3 molecule. That's not the only one that will be used in the future because there's a lot of work being done on other types of T-cell engagers.” TS 4:21 “The targets for lymphoma are CD20. Those are bispecific T-cell engagers that hit CD20 on the lymphoma cell, as well as CD3 on a T cell. ... In myeloma, we have two different targets that have been utilized. One is BCMA or B-cell maturation antigen. That sits on the surface of myeloma cells and on some healthy B cells. ... There's also a target used in myeloma that's called GPRC5D, which stands for G protein–coupled receptor, class C, group 5, member D. ... In small cell lung cancer, there's delta-like ligand 3 (DLL3); it's part of the NOTCH pathway. ... And then this year, we've had a couple agents come out that target HER2.” TS 6:52 “[Toxicities] are very dependent on what your target is. ... The bispecific T-cell engager that's used in myeloma that targets the GPRC5D is also expressed on tissues that produce hard keratin like hair follicles and actually, within the tongue. So the toxicities that we see with that agent are something you wouldn't expect to see if you were using a myeloma agent. You see nail and skin issues. You see taste problems. So it's very specific about the target, which says to me, that every time a new one of these agents comes out, I have to learn about the target that helps me learn about the toxicity. I find that fascinating and really appreciate that.” TS 16:19 “Cytokine release syndrome has been one of the areas that drug development has really focused on to see how they can help mitigate the severity [of it]. ... [One of] the strategies that has been incorporated and studied in clinical trials is the step-up dosing scheme. [It's] where you give initial small doses and over time, increase the dose to the dose you're going to continue with. Usually, monitoring in the hospital is required by the FDA approval for anywhere from 28–48 hours for the first couple of doses. And that's a real common strategy that you'll see. Premedication with H2 blockers, H1 blockers, sometimes steroids. These are also things that are incorporated within the approvals of these drugs and are important to look at.” TS 20:53

This week, we're joined by Jenna Kokoski, a BCBA with over 20 years of experience in the ABA field. Jenna is the COO of Jade Health and a leader in the ABA community, known for her advocacy, expertise, and dedication to creating ethical and sustainable business models. She's here to talk about the importance of accreditation in ensuring quality care in ABA, what families should look for in a provider, and how accreditation benefits both families and individuals with autism. Download to learn more!  Resources  Jade Health's Suite of Offerings Include: BHCOE Accreditation |National Autism Data Registry | Credentialing and Contracting | Jade Health Learning Hub | Quickstart ABA   Schedule a Meeting  Connect on Social Media ............................................................... Autism weekly is now found on all of the major listening apps including apple podcasts, stitcher, Spotify, amazon music, and more. Subscribe to be notified when we post a new podcast. Autism weekly is produced by ABS Kids. ABS Kids is proud to provide diagnostic assessments and ABA therapy to children with developmental delays like Autism Spectrum Disorder. You can learn more about ABS Kids and the Autism Weekly podcast by visiting abskids.com.  

This program, led by Christiaan Scott, MD, Professor of Pediatric Rheumatology at the University of Ottawa and Raphaella Stander, MBCHB, Pediatrician at Atlantic Children's Practice, focused  on three case studies to provide physicians with education on best practices to: 1) suspect and diagnose FOP, 2) monitor and manage younger children with FOP, and 3) monitor and manage older children and adults with FOP. This accredited CME program provides healthcare professional with timely and practical education on fibrodysplasia ossificans progressiva (FOP). It is supported by an educational grant from Ipsen Biopharmaceuticals.To obtain CME credit, visit https://checkrare.com/learning/p-case-studies-in-diagnosing-and-managing-fop/ Target AudienceThis activity has been designed to meet the educational needs of physicians specializing in pediatrics, rheumatology, genetics, family medicine, and orthopedics. Other members of the care team may also participate.Learning ObjectivesAfter participating in the activity, learners should be better able to:Apply best practices for suspecting and diagnosing FOP.List best practices for managing young children with FOP.Identify best practices to manage older children and adults with FOP.Christiaan Scott, Professor of Medicine, University of OttawaRaphaella Stander, MBCHB, Pediatrician, Atlantic Children's PracticeDisclosure StatementAccording to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated.Disclosure of relevant financial relationships are as follows:Faculty Educator/PlannerDr. Scott discloses the following relevant financial relationships with ineligible companies:Grant/Research Support: Regeneron*, Incyte*, Janssen*, Roche*; Speaker's Bureau:  Ipsen*, Regeneron*, Springer*, Jannsen**Relationships have endedDr. Stander has no relevant financial relationships with ineligible companies.Other Planners for this activity have no relevant financial relationships with any ineligible companies.This activity will review off-label or investigational information.The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or CheckRare CE. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.Accreditation and Credit DesignationIn support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and CheckRare CE. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.PhysiciansAmerican Academy of CME, Inc., designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other HCPsOther members of the care team will receive a certificate of participation.There are no fees to participate in the activity.  Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME credit for your participation, please complete the pre and post-program assessments. Your certificate will be emailed to you within 30 days.PrivacyFor more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm  For more information about CheckRare's privacy policy, please access https://checkrare.com/privacy/ContactFor any questions, please contact: CEServices@academycme.orgCopyright© 2025. This CME-certified activity is held as copyrighted © by American Academy of CME and CheckRare CE. Through this notice, the Academy and CheckRare CE grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

In this episode, hear from Brian Polk, Director of Accreditation at the Society for Classical Education. Learn about how SCL is doing accreditation with a view to helping classical schools flourish. Find out more about what it looks like to have a visiting team at your school and steps you can take to explore accreditation through SCL.Links from this episode:SCL Accreditation webpagePrevious episode: AccreditationThe Educational Renaissance Podcast is a production of ⁠⁠⁠⁠⁠Educational Renaissance⁠⁠⁠⁠⁠ where we promote a rebirth of ancient wisdom for the modern era. We seek to inspire educators by fusing the best of modern research with the insights of the great philosophers of education. Join us in the great conversation and share with a friend or colleague to keep the renaissance spreading.Take a deeper dive into training resources produced by Educational Renaissance such as Dr. Patrick Egan's new book entitled Training the Prophetic Voice available now through ⁠⁠⁠⁠⁠⁠⁠⁠⁠Amazon⁠⁠⁠⁠⁠⁠⁠⁠⁠.

A simple, must-know guide to ARC-PA terms, probation vs. provisional, and how to vet programs before you hit submit. This is exactly what you need to know when it comes to PA program accreditation and applying to PA schools!CASPA SOS: Last Call Bootcamp — your step-by-step plan to submit (or strengthen) your PA school app before any more deadlines hit. Happening October 12 >> Walk in confused, walk out with a prioritized checklist, expert feedback, and a clear next step for your stage—submitted, not yet, or next cycle!Be the one who gets interviews, not rejections!→ Join now here! We can't wait to see you there! Keep up the amazing work, future PA! Beth & Katie

“I think sometimes people don't expect pediatric patients to handle radiation as well as they do. They may have a family member who also had radiation for breast cancer or for prostate cancer and they were an older adult and had really severe side effects. And then they say, ‘Oh, no, I've got to put my little baby through this. I don't really want to do this.' We say kids are very different in how they handle this. They're very resilient, so we can provide good education about that,” Elizabeth Cummings, MSN, CPNP-AC, CPHON®, radiation oncology nurse practitioner at Children's Hospital of Philadelphia in Pennsylvania, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about radiation treatment care for pediatric patients. Music Credit: “Fireflies and Stardust” by Kevin MacLeod  Licensed under Creative Commons by Attribution 3.0   Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by September 26, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.  Learning outcome: Learner will report an increase in knowledge related to radiation oncology treatment care for pediatric patients. Episode Notes   Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 365: Radiation-Associated Secondary Cancers Episode 301: Radiation Oncology: Side Effect and Care Coordination Best Practices Episode 298: Radiation Oncology: Nursing's Essential Roles Episode 204: How Radiation Is Used in Palliative Care Episode 50: Difficult Decisions in Childhood Cancer ONS Voice articles: Fertility Preservation Protects Possibilities for Patients With Cancer Have Meaningful Conversations With Pediatric, Adolescent, and Young Adult Patients and Their Families Pediatric Cancer Survivors Require Additional Care and Monitoring Prepare Survivors for the Risk of Secondary Cancers Secondary Cancers in Pediatric Survivors ONS book: Manual for Radiation Oncology Nursing Practice and Education (Fifth Edition) ONS courses: Essentials in Survivorship Care for the Advanced Practice Provider ONS/ONCC® Radiation Therapy Certificate™ Clinical Journal of Oncology Nursing articles: Radiation Therapy Survivorship: Healthcare Providers' Perspectives on Education and Care Radiation Therapy: Understanding the Patient Experience Reducing Pediatric Patient Anxiety: Implementing a Nonpharmacologic Intervention to Aid Patients Undergoing Radiation Therapy Other ONS Resources Inclusive Care Learning Library Late Effects of Cancer Treatment Huddle Card Proton Therapy Huddle Card Radiation Huddle Card Radiation Learning Library Oncolink Jr. Pediatric Radiation Oncology Society  To discuss the information in this episode with other oncology nurses, visit the ONS Communities.   To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library.  To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode  “I think one of the things to think about with kids is sometimes they're not as forthcoming with what's going on, and sometimes it's a little bit harder to understand. Sometimes that's just because developmentally, they're much younger. A 1-year-old can't exactly tell you what's wrong. And so you're really trying to figure it out based on their cues versus a teenager who can tell you, but maybe they're too embarrassed about something in a way that an adult might not be.” TS 7:01 “Child life specialists are incredible. ... They provide age-appropriate education and explanations for patients, so talking to a 3-year-old about cancer is very different from an 8-year-old or even a teenager. They really are able to meet each patient exactly where they are and at the level that they are, and then provide the appropriate amount of information, which is so helpful for a patient since they learn to build trust and cope with their treatment and [they feel like they] have somebody who can relay that information in a clear and concise way.” TS 11:16 “There's certainly growing concern about the potential effects of anesthesia on brain health, especially in a vulnerable population like very young children, which are the ones who need anesthesia. We really try to mitigate this by optimizing our anesthetic agents, so we'll use propofol, which has a really quick onset and offset. And even when the radiation treatment is done, they'll stop the propofol in the radiation room—even though they are still walking back to recovery, just to minimize the amount of time that it's on—and trying to use the lowest dose possible. We also [explore] a lot of nonanesthetic strategies, [like] child life support, trying to introduce video distraction when we can, and having music and audiobooks.” TS 17:47 “[In] pediatrics, the patient, not the parent, is your patient. And that can look really different for a 3-year-old versus a 17-year-old. Somebody who can't officially sign consent, but they certainly have a lot of buy-in about the things that reach their body, versus a 3-year-old, where the parents are really taking ownership of that. I think sometimes it's tricky in the world of pediatrics as we think about the ethics of ‘Who are we training here? Is it the patients? Is it the parents?' And we continue to advocate for our patients.” TS 23:32 “I think that pediatric patients still want to be normal kids. They still want to do their normal activities. ... Our pediatric patients, a lot of times, have healthier tissues. They haven't seen as much wear and tear. They haven't developed the bad habits of some adults. They don't have the same environmental exposures, they're not smoking, they probably have fewer comorbidities. ... They're a different population. ... They're just amazing. They still want to be a kid, they still want to go to school, they still want to be with their friends. It's really encouraging to see that.” TS 36:03 

Cameron is joined by Jennifer Hartley, founder of Skin Synthesis, who shares her journey from critical care nursing to establishing her own aesthetics practice. They discuss the challenges of launching a business during the pandemic, the importance of continuous education, networking, and the philosophy behind her practice that focuses on natural results and building long-term relationships with patients. Jennifer also reflects on humbling moments in her practice and the significance of honesty and boundaries in patient care, as well as the role of technology in enhancing patient experiences.Cameron and Jennifer talk about the importance of building strong patient relationships, elevating treatment planning, and the significance of legal compliance in aesthetic practices. They emphasize the need for intentional learning at conferences and prioritizing patient care over profits,. The dialogue highlights the balance between business acumen and patient-centered care in the medical aesthetics industry.Listen In!Thank you for listening to this episode of Medical Millionaire!Takeaways:Jennifer transitioned from critical care to aesthetics to help people live well.The hustle of entrepreneurship requires grit and dedication.Investing in education is crucial for success in aesthetics.Networking is essential for support and growth in the industry.Skin Synthesis focuses on natural results and long-term patient relationships.Humbling moments in aesthetics can be profoundly impactful.Honesty and setting boundaries with patients is vital.Technology plays a significant role in enhancing patient communication.The pandemic presented unique challenges for launching a business.Confidence restoration is a key aspect of aesthetic practice. Building relationships is key to patient loyalty.Follow-up communication enhances patient retention.Elevating treatment plans can improve patient experience.Intentional learning at conferences leads to actionable insights.Legal compliance is crucial for aesthetic practices.Prioritizing patient care can lead to long-term success.Investing in team training is essential for growth.Understanding financials is important but shouldn't overshadow patient care.Accreditation can raise industry standards.Continuous passion for aesthetic medicine is vital for success.Unlock the Secrets to Success in Medical Aesthetics & Wellness with "Medical Millionaire"Welcome to "Medical Millionaire," the essential podcast for owners and entrepreneurs inMedspas, Plastic Surgery, Dermatology, Cosmetic Dental, and Elective Wellness Practices! Dive deep into marketing strategies, scaling your medical practice, attracting high-end clients, and staying ahead with the latest industry trends. Our episodes are packed with insights from industry leaders to boost revenue, enhance patient satisfaction, and master marketing techniques.Our Host, Cameron Hemphill, has been in Aesthetics for over 10 years and has supported over 1,000 Practices, including 2,300 providers. He has worked with some of the industry's most well-recognized brands, practice owners, and key opinion leaders.Tune in every week to transform your practice into a thriving, profitable venture with expert guidance on the following categories...-Marketing-CRM-Patient Bookings-Industry Trends Backed By Data-EMR's-Finance-Sales-Mindset-Workflow Automation-Technology-Tech Stack-Patient RetentionLearn how to take your Medical Aesthetics Practice from the following stages....-Startup-Growth-Optimize-Exit Inquire Here:http://get.growth99.com/mm/

Accreditation sits at the heart of higher education's promise to deliver value, quality, and opportunity. But in 2025, the landscape is shifting fast, fueled by questions of accountability, the rise of alternative accreditors, and new expectations around data and student success. In this episode of CCA on the Air, we sit down with Dr. Maria Toyoda, the new President and CEO of WSCUC. Together, we explore how WSCUC is using data to drive innovation, the role of accreditation in the evolving higher education landscape, and how accreditors can balance rigorous standards with access, student success, and innovation.

It's YOUR time to #EdUpIn this episode, part of our Academic Integrity Series, sponsored by ⁠Pangram Labs,⁠YOUR guest is ⁠Dr. Heather Perfetti, President & CEO, Middle States Commission on Higher EducationYOUR cohost is ⁠Bradley Emi , ⁠Cofounder & CTO, ⁠Pangram Labs⁠YOUR host is ⁠Elvin Freytes⁠How does Dr. Perfetti define academic integrity through the lens of accreditation standards & why does she emphasize centering students around academic rigor & holistic learning experiences? What makes Middle States Commission unique as a global institutional accreditor serving over 500 institutions worldwide & how do they work as part of the regulatory triad? How is Dr. Perfetti supporting institutions navigating AI integration while maintaining academic integrity & transparency in their accreditation processes?Listen in to #EdUpThank YOU so much for tuning in. Join us on the next episode for YOUR time to EdUp!Connect with YOUR EdUp Team - ⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠Elvin Freytes⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠& ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Dr. Joe Sallustio⁠⁠⁠⁠⁠● Join YOUR EdUp community at ⁠The EdUp Experience⁠We make education YOUR business!P.S. Want to get early, ad-free access & exclusive leadership content to help support the show? Then ⁠⁠​subscribe today​⁠⁠ to lock in YOUR $5.99/m lifetime supporters rate! This offer ends December 31, 2025!

This week we sit down with Lauren Bozich, MS, RD, LDN, Senior Director of Accreditation at ACEND. This episode provides an important update since our conversation with Dr. Rayane AbuSabha last year. Starting this year, all supervised practice and graduate programs accredited through ACEND must follow the new DICAS application process.Bozich walks us through the changes, explaining key dates, what they mean for students, how to prepare strong applications, and the overall benefits of this streamlined system. With her expertise, listeners will gain clarity and confidence in navigating this transition.For more details, visit ACEND's website: https://www.eatrightpro.org/acend/students-and-advancing-education/students-and-advancing-education-intro

Third week of September, what'd you miss in vet med?NY Lawmakers propose AG Oversight on AcquistionsLMU Orange Park receives COE AccreditationGallant brings education to PractionersEmbrace Pet Insurance ScholarshipTribute to my dog WalterHelpful links:The Bird Bath substackNVA: Associate Veterinarian Humber Veterinary Clinic - Job Description

The accredited CME program highlights the latest clinical research about hemophilia, a rare, genetic bleeding disorder. Led by Dr. Steven Pipe, MD, this activity provides a summary of clinically relevant data presented at the International Society of Thrombosis and Haemostatis Congress (ISTH 2025) that can enhance the care of patients with hemophilia. This program is supported by an educational grant from Sanofi.To receive CME credit, visit https://checkrare.com/learning/p-isth2025-module1-hemophilia-clinical-research-highlights/Target AudienceThis activity has been designed to meet the educational needs of physicians specializing in hemophilia. Other members of the care team may also participate.Learning ObjectivesAfter participating in the activity, learners should be better able to:Describe the latest research being presented to better manage individuals with hemophilia and its clinical relevance.Steven Pipe, MDProfessor of Medicine,University of Michigan Disclosure StatementAccording to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated. Disclosure of relevant financial relationships are as follows:Faculty Educator/PlannerDr. Pipe discloses the following relevant financial relationships with ineligible companies:Consultant: Bayer, BioMarin, CSL Behring, Hema Biologics, Inovio, LFB, Metagenomi, Novo Nordisk, Pfizer, Poseida Therapeutics, Roche/Genentech, Sanofi, Takeda, Spark TherapeuticsScientific Advisory Committee: GeneVentiv, Equilibra BioscienceGrant/Research Support: Siemens, YewSaving Other Planners for this activity have no relevant financial relationships with any ineligible companies. This activity will review off-label or investigational information. The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or CheckRare CE. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information. Accreditation and Credit DesignationIn support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and CheckRare CE. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.PhysiciansAmerican Academy of CME, Inc., designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other HCPsOther members of the care team will receive a certificate of participation. ContactFor any questions, please contact: CEServices@academycme.orgCopyright© 2025. This CME-certified activity is held as copyrighted © by American Academy of CME and CheckRare CE. Through this notice, the Academy and CheckRare CE grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

The accredited CME program highlights the latest clinical research about iTTP, a rare thrombotic disorder. Led by Shruti Chaturvedi, MD, this activity provides a summary of clinically relevant data presented at the International Society of Thrombosis and Haemostatis Congress (ISTH 2025) that can enhance the care of patients with iTTP. This program is supported by an educational grant from Sanofi.To receive CME credit, go to https://checkrare.com/learning/p-isth2025-module3-immune-thrombotic-thrombocytopenic-purpura-ittp-clinical-research-highlights/Target AudienceThis activity has been designed to meet the educational needs of physicians specializing in iTTP. Other members of the care team may also participate.Learning ObjectivesAfter participating in the activity, learners should be better able to:Describe the latest research being presented to better manage individuals with iTTP and its clinical relevance. Shruti Chaturvedi, MDAssistant Professor of MedicineJohns Hopkins Disclosure StatementAccording to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated. Disclosure of relevant financial relationships are as follows:Faculty Educator/PlannerDr. Chaturvedi discloses the following relevant financial relationships with ineligible companies:Scientific Advisory Board/Consultant: Sanofi, Takeda, Sobi, argenx, Star Pharma, RallyBio, Novartis, AlexionGrant/Research Support: Sanofi, Sobi, argenx Other Planners for this activity have no relevant financial relationships with any ineligible companies. This activity will review off-label or investigational information. The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or CheckRare CE. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information. Accreditation and Credit DesignationIn support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and CheckRare CE. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.PhysiciansAmerican Academy of CME, Inc., designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other HCPsOther members of the care team will receive a certificate of participation. There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME credit for your participation, please complete the pre and post-program assessments. Your certificate will be emailed to you within 30 days. PrivacyFor more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm  For more information about CheckRare's privacy policy, please access https://checkrare.com/privacy/ContactFor any questions, please contact: CEServices@academycme.orgCopyright© 2025. This CME-certified activity is held as copyrighted © by American Academy of CME and CheckRare CE. Through this notice, the Academy and CheckRare CE grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

This accredited CME program highlights the latest clinical research about immune thrombocytopenia (ITP), a rare thrombotic disorder. Led by Shruti Chaturvedi, MD, this program provides a summary of clinically relevant data presented at the International Society of Thrombosis and Haemostatis Congress (ISTH 2025) that can enhance the care of patients with ITP. This program is supported by an educational grant from Sanofi.To receive CME credit, go to https://checkrare.com/learning/p-isth2025-module2-immune-thrombocytopenia-clinical-research-highlights/Target AudienceThis activity has been designed to meet the educational needs of physicians specializing in ITP. Other members of the care team may also participate.Learning ObjectivesAfter participating in the activity, learners should be better able to:Describe the latest research being presented to better manage individuals with ITP and its clinical relevance.FacultyShruti Chaturvedi, MDAssistant Professor of Medicine,Johns Hopkins Disclosure StatementAccording to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated. Disclosure of relevant financial relationships are as follows:Faculty Educator/PlannerDr. Chaturvedi discloses the following relevant financial relationships with ineligible companies:Scientific Advisory Board/Consultant: Sanofi, Takeda, Sobi, argenx, Star Pharma, RallyBio, Novartis, AlexionGrant/Research Support: Sanofi, Sobi, argenx Other Planners for this activity have no relevant financial relationships with any ineligible companies. This activity will review off-label or investigational information. The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or CheckRare CE. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.Accreditation and Credit DesignationIn support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and CheckRare CE. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.PhysiciansAmerican Academy of CME, Inc., designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other HCPsOther members of the care team will receive a certificate of participation. There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME credit for your participation, please complete the pre and post-program assessments. Your certificate will be emailed to you within 30 days. PrivacyFor more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm  For more information about CheckRare's privacy policy, please access https://checkrare.com/privacy/ContactFor any questions, please contact: CEServices@academycme.orgCopyright© 2025. This CME-certified activity is held as copyrighted © by American Academy of CME and CheckRare CE. Through this notice, the Academy and CheckRare CE grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

We break down the core Circumplex orientation - Satisfaction (growth) vs Security (protection). Learn how state of mind drives behavior, why confidence is quiet, and practical ways to shift from defensiveness to growth. View the full show notes here: https://www.human-synergistics.com.au/resources/culture-insights-blog/satisfaction-vs-security-what-it-is-and-why-it-matters-culture-bites-248/ Consulting Solutions: https://www.human-synergistics.com.au/our-services/consulting/ Diagnostics: https://www.human-synergistics.com.au/our-diagnostics/ Accreditation: https://www.human-synergistics.com.au/become-accredited/

  “One powerful, overlooked aspect of colorectal cancer survivorship is the emotional and identity transformation that our survivors undergo—and really how little space is given in the clinical arena for that. No one really talks about this ‘invisible recovery.' Facing mortality can lead to prolonged changes is values, relationships, and life goals. And these experiences aren't captured in lab results or imaging scans, but they really shape how survivors live, love, and heal and continue with their lives,” ONS member Kris Mathey, DNP, APRN-CNP, AOCNP®, gastrointestinal medical oncology nurse practitioner at The James Cancer Hospital of The Ohio State University Wexner Medical Center in Columbus, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about colorectal cancer survivorship. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by September 12, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learner will report an increase is knowledge related to colorectal cancer survivorship nursing considerations. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 374: Colorectal Cancer Treatment Considerations for Nurses Episode 370: Colorectal Cancer Screening, Early Detection, and Disparities Episode 201: Which Survivorship Care Model Is Right for Your Patient? Episode 153: Metastatic Colorectal Cancer Has More Treatment Options Than Ever Before ONS Voice articles: Genetic Disorder Reference Sheet: Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Here Are the Current Nutrition and Physical Activity Recommendations for Cancer Survivors ONS course: Essentials in Survivorship Care for the Advanced Practice Provider Clinical Journal of Oncology Nursing article: Closing the Gaps: Addressing the Unmet Needs of Cancer Survivors Oncology Nursing Forum articles: Symptom Occurrence, Frequency, and Severity During Acute Colorectal Cancer Survivorship The Relationship Between Colorectal Cancer Survivors' Positive Psychology, Symptom Characteristics, and Prior Trauma During Acute Cancer Survivorship ONS Survivorship Care Plan Huddle Card ONS Learning Libraries: Colorectal cancer Survivorship Academy of Oncology Nurse and Patient Navigators American Cancer Society National Colorectal Cancer Roundtable Colorectal Cancer Alliance Colorectal Cancer Resource and Action Network Fight Colorectal Cancer Resource Library Livestrong at the YMCA Pan Ohio Hope Ride To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “As of the most recent data, more than 1.5 million people in the United States are living as colorectal cancer survivors. So this includes not only those who are currently undergoing active cancer treatment but also those who have completed treatment and ultimately are hopefully in remission. Just a reminder that colon cancer is the third most commonly diagnosed cancer in the United States and it's the fourth leading cause of cancer-related deaths.” TS 1:53 “Our colorectal cancer survivors may have significant barriers when receiving this comprehensive survivorship care, and these challenges can affect not only their physical recovery but their emotional well-being and, ultimately, their long-term health outcomes. We as oncology nurses do play a pivotal role in identifying and addressing these barriers. So these can include fragmented care. Who's caring for these patients? That care coordination between the oncologist and the oncology team and then the primary care providers and team. Limited access—so our patients that may have geographic limited access or also financial- or insurance-related obstacles to follow-up services.” TS 9:10 “Our nurses can also facilitate the communication between specialists and primary care providers, so making sure that we're sending records, keeping those lines of communications open. Also, nurses can provide that psychosocial support, so our screening for distress and also advocating and supporting for referral to counseling or support groups for a patient. Nurses can also act as navigators to guide these patients through complex care systems.” TS 11:21 “Some of the recommended changes—nutrition—enhancing and emphasizing fruits, vegetables, that colorful plate, with whole grains. Limit those red and processed meats, and reduce sugary drinks and alcohol. I know we will all have those patients who have read things or cancer myths about, ‘Oh, cancer feeds on sugar, so I shouldn't drink anything or eat anything with sugar,' and maybe addressing that, just really emphasizing the well-rounded meals.” TS 19:57 “When we think about [ourselves], ‘Well, I don't have an implicit bias,' but we may not think about what that is. Some common preconceived assumptions are that survivorship equals a cure. And this assumption may overlook that chronic symptoms or those late effects and emotional needs of long-term survivors. So knowing that when a patient is coming to us on surveillance, they may be cured; they may not have active cancer, but they're still dealing with some of those chronic symptoms—and acknowledging that.” TS 30:37 “There's an assumption that an ostomy equals poor quality of life, and this may stigmatize patients and discourage open conversations about adaptation and support. A couple weeks ago, I volunteered at the Pan Ohio Hope Ride, which is with the American Cancer Society, and several states have a ride that's similar. And there was a patient riding, and I could tell over his jersey that he had an ostomy bag underneath that. And I just looked at him and I thought, ‘That's amazing. You are still functioning, still living, still riding a bike throughout the entire state of Ohio with an ostomy.' So he's still having that good quality of life. That doesn't stop him from living.” TS 31:39

Host Jeremy C. Park talks with Jim Bartoo, Marketing and Public Relations Director with Nashville Zoo, who discusses the zoo's history, growth and development, and commitment to animal welfare, along with the importance of accreditation by the Association of Zoos & Aquariums. He highlights the zoo's conservation efforts, both local and global, as well as their educational programs and upcoming events. The conversation also covers the zoo's unique features, including exhibit design and animal care, and ways for the public to support and enjoy the zoo's experiences.Nashville Zoo's Philosophy and DevelopmentsDuring the interview, Jim provides an overview of Nashville Zoo's history, location, and recent developments. He explains that the zoo, which moved to its current location in 1996, has been built from the ground up, allowing for the implementation of the latest philosophies and technologies for animal care and habitat development. Jim also discusses the shift in zoo philosophy from focusing on cleanliness and sterilization to prioritizing animal welfare and creating environments that promote animal happiness and comfort.Importance of AZA Accreditation for ZoosJim discusses the importance of accreditation by the Association of Zoos & Aquariums (AZA) for zoos in the United States. He explains that while all zoos must have a USDA license for animal care, AZA accreditation goes well beyond the minimum standards, focusing on animal health, veterinary care, education, and conservation efforts. This accreditation is a gold standard for animal care and is required every five years as the standards evolve. Jim emphasizes that AZA accreditation is crucial for visitors to ensure they are supporting zoos that prioritize animal welfare.Nashville Zoo's Conservation and Education EffortsJim discusses Nashville Zoo's conservation efforts, which include local and global initiatives. The zoo works with organizations like TWRA and USDA to protect streams and environments in Tennessee, conducting head start programs and monitoring waterways. Internationally, they study animal migration patterns, such as giraffe movements in Africa, to address habitat fragmentation issues. The zoo also focuses on education, offering programs for all ages and taking ambassador animals to schools and nursing homes.Nashville Zoo Upcoming EventsJim also highlights upcoming events at Nashville Zoo, including the upcoming opening of a new exhibit, Leopard Forest, the Zzzoofari Slumber camp out on May 24, Brew at the Zoo on June 13, and Summer Splash Saturdays in July and August. Jim encourages public support through memberships, donations, and corporate sponsorships to help fund new exhibits and conservation work.Visit https://www.nashvillezoo.org to learn more.

“All of these TKIs [tyrosine kinase inhibitors] inhibit BCR-ABL1 in some way, shape, or form. When BCR-ABL1 is mutated, it has uncontrolled tyrosine kinase activity, leading to rapid cell proliferation. When we then inhibit that BCR-ABL1 that's been mutated, we disrupt this abnormal signaling pathway that drives CML [chronic myeloid leukemia] cell proliferation and survival, ultimately leading to decreased cancer cell growth, increased apoptosis or cell death, and potentially inducing a disease remission,” Samantha Maples, PharmD, BCOP, clinical pharmacy specialist supervisor for hematology and cellular therapy at Allegheny Health Network in Pittsburgh, PA, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about the BCR-ABL1 inhibitor drug class.   Music Credit: “Fireflies and Stardust” by Kevin MacLeod  Licensed under Creative Commons by Attribution 3.0   Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by September 5, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.  Learning outcome: Learner will report an increase in knowledge related to the use of BCR-ABL1 inhibitors in the treatment of CML. Episode Notes   Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Pharmacology 101 series Episode 322: Nursing Strategies to Reduce Readmission Rates for Patients With Cancer Episode 215: Navigate Updates in Oral Adherence to Cancer Therapies ONS Voice articles: Adherence to Oral Anticancer Medication Combination Therapy Shows Promise for Chronic Myeloid Leukemia The Case of the Medication Modification The Case of the Safety Session ONS course: Safe Handling Basics Clinical Journal of Oncology Nursing articles: Targeted Drug Therapies: Beyond Blood Counts and Chemistries Oncology Nursing Forum articles: Adherence and Coping Strategies in Outpatients With Chronic Myeloid Leukemia Receiving Oral Tyrosine Kinase Inhibitors Fear of Progression in Outpatients With Chronic Myeloid Leukemia on Oral Tyrosine Kinase Inhibitors Other ONS resources: Biomarker Database Financial Toxicity Huddle Card Tyrosine Kinase Inhibitors Huddle Card Oral Anticancer Medication Care Compass: Resources for Interprofessional Navigation Oral Anticancer Medication Learning Library National Comprehensive Cancer Network National Comprehensive Cancer Network patient resources To discuss the information in this episode with other oncology nurses, visit the ONS Communities.   To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library.  To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode  “The IRIS study led to the approval of the BCR-ABL1 and TKI, imatinib, for CML in 2001 and completely changed the landscape of CML treatment. Then came the second-generation BCR-ABL1 TKIs: dasatinib in 2006, quickly followed by nilotinib in 2007. Thereafter came our second-generation, bosutinib, and our first approved third-generation TKI, ponatinib, both in 2012, which was a huge milestone as ponatinib overcomes resistance to the T315 I mutation, which no previously approved TKIs worked against.” TS 2:16 “The newest approved TKI, asciminib, is an allosteric inhibitor that binds to a different pocket on the BCR-ABL kinase via allosteric binding to the ABL myristoyl pocket. It's what's called a STAMP inhibitor, where STAMP stands for ‘specifically targeting the ABL myristoyl pocket.' And while all the TKIs target the BCR-ABL1 binding site, they can also inhibit different off-target kinases. And these differences in off-target inhibition are responsible for some of the different toxicities we see among the TKIs.” TS 4:51 “As a class, common toxicities include nausea; vomiting; diarrhea; cardiac toxicities, including cardiac arrhythmias and congestive heart failure; metabolic abnormalities such as hypercholesterolemia and hypertriglyceridemia; nephrotoxicity; hepatic toxicity; hemorrhaging and bleeding; as well as cytopenia. Individually, some of these agents are more likely to cause certain side effects compared to others, and there are unique toxicities associated with certain TKIs.” TS 8:10 “We've moved to using preemptive loperamide [in our clinic] for the first three days of starting treatment, because it's really hard to get patients to continue to take a medication if they have such severe diarrhea that they end up in the hospital or they're unable to leave their house. A lot of times, we will proactively give patients antiemetics and loperamide to help with the nausea, vomiting, and diarrhea. And then we can back off to an as-needed basis once they've been established on treatment. We can also use medications to help manage long-term complications that can require supportive care, such as statin therapy for high cholesterol, levothyroxine for hypothyroidism, anticoagulants for any venous thromboembolism, and antihypertensive medications for managing any new or worsening high blood pressure.” TS 12:44 “We are continually seeing these agents expand their indications to different lines of therapy, as well as more TKIs being approved for acute lymphoblastic leukemia. For example, asciminib just got approved in the frontline setting within the last year, whereas previously it was only approved in relapsed refractory setting. Last year, imatinib was the first BCR-ABL1 TKI to come out with a commercially supplied suspension option as well, which is huge in the pediatric space and [for] our adult patients who are unable to swallow tablets for other clinical reasons.” TS 21:22 “There is more information being published on the safe discontinuation of these medications with treatment-free remissions, and more information is coming out about who would be eligible and who can have the option to stop these treatments instead of having a lifelong chronic condition requiring continuous treatment. We're seeing more patients in clinical practice be able to stop BCR-ABL1 treatment, which has been a great development in CML.” TS 25:29

“Policies help make sure that we're giving patients the right education and discharge instructions. Radiation doesn't end when the syringe is empty. Patients go home with potential radioactive exposure. They need to know how to protect their families, what precautions to take, and what healthcare providers can do if something goes wrong—like a spill, extravasation, or even a pregnant staff member who's involved in the care. This isn't just a documentation exercise. It's about making sure every part of the system speaks the same language when it comes to safety, handling, and patient care,” ONS member Ella-Mae Shupe, MSN, RN, OCN®, nursing practice and professional development specialist for radiation oncology at Johns Hopkins Health System Sydney Kimmel Cancer Center based in Baltimore, MD, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about creating and implementing radiopharmaceutical policies and procedures.  Music Credit: “Fireflies and Stardust” by Kevin MacLeod  Licensed under Creative Commons by Attribution 3.0   Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by August 22, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.  Learning outcome: Learner will report an increase in knowledge related to implementing policies and procedures to support administration of radiopharmaceuticals for cancer treatment. Episode Notes   Complete this evaluation for free NCPD. ONS Podcast™ episodes: Episode 347: Care Considerations for Radiopharmaceuticals and Theranostics in Patients With Cancer Episode 301: Radiation Oncology: Side Effect and Care Coordination Best Practices Episode 298: Radiation Oncology: Nursing's Essential Roles Episode 104: How Radiation Affects All Areas of Oncology Nursing ONS Voice articles: New Radiopharmaceutical Improves Survival in Advanced Prostate Cancer Radiopharmaceuticals and Theranostics Offer New Options for Oncology Nurses to Transform Cancer Care Radiopharmaceuticals Pack a One-Two Punch Against Cancer Safety Is Key in Use of Radiopharmaceuticals ONS Voice oncology drug reference sheets: Lutetium Lu 177 Dotatate Lutetium Lu 177 Vipivotide Tetraxetan Radium 223 Dichloride Sodium Iodide-131 ONS book: Manual for Radiation Oncology Nursing Practice and Education (Fifth Edition) ONS course: ONS/ONCC® Radiation Therapy Certificate™ Clinical Journal of Oncology Nursing article: Nursing Telemedicine Educational Encounters: Improved Patient Satisfaction in Radiation Therapy Clinics Other ONS resources: ONS Radiation Learning Library ONS Radiation Safety: In the Home Huddle Card ONS Radiopharmaceuticals Huddle Card Daily Med Lutathera® website for healthcare professionals Pluvicto® website for healthcare professionals Xofigo® website for healthcare professionals To discuss the information in this episode with other oncology nurses, visit the ONS Communities.   To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library.  To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode  “[Lutetium lu 177 vipivotide tetraxetan] has shown so effective in clinical studies that the FDA recently approved expanded use, and it can now be given prior to chemotherapy.” TS 1:56 “There are typically three parts to a radiopharmaceutical. One is a radioisotope, which emits the radiation. The second is a targeting molecule, which directs the compound to a specific site. And the third is a linker that binds the isotope to the targeting molecules securely. The targeting molecule is usually a substance that binds specifically to receptors, antigens, or metabolic pathways that are overexpressed on cancer cells.” TS 2:08  “We have an interdisciplinary team involvement. There's a physicist, nurse, and provider that confirm lab values are within normal limits. The patient meets all the clinical and safety criteria for administration. Second is an IV placement where a nurse or clin tech starts the IV and verifies a strong blood return. This is critical to avoid extravasation, which can be harmful due to the vesicant-like nature of radiopharmaceuticals. And third, our patient voids immediately before the injection, which reduces bladder radiation dose. During the administration, our provider administers the radiopharmaceutical using a shielded syringe holder to reduce radiation exposure. The physicist remains present throughout the procedure. Lead aprons are worn by any team members close to the IV site, and then the Geiger counter is used by physics to measure ionizing radiation, which is done before, during, and after the procedure.” TS 3:28 “The policy we created doesn't just address general principles. It includes very specific guidance for both [radium 223 dichloride] and [lutetium lu 177 vipivotide tetraxetan]. That includes everything from determining patient eligibility to completing the treatment directive, confirming patient identity, verifying delivery parameters, documenting the treatment itself, and ensuring the treatment environment is appropriate and safe. We've also built in drug- specific practices because [radium 223 dichloride] and [lutetium lu 177 vipivotide tetraxetan] each come with their own considerations. This includes competencies for nursing, tailored patient education for each therapy, and an extravasation checklist that outlines what to do and who's responsible for tasks if infiltration occurs.”TS 11:24 “We created two separate versions [of an attestation model], one for clinical staff and one for non-clinical staff. Why include non-clinical staff? Because the risks extend beyond just the clinical team. What if environmental services comes in to clean and the patient has urinated on the floor? Or what if dietary delivers a tray and moves a urinal without knowing the risk? Or what if transport comes in and handles an incontinent brief without awareness? Each of these scenarios has potential for contamination and exposure. And that's exactly why education for all roles matter.” TS 15:22 “These are such an exciting treatment for our patients, that's not chemotherapy, that's not radiation, and their quality of life has been amazing. We have had patients coming in that could barely walk because of the pain from bone mets and after a few treatments, they're much better. We've had PSAs go from five, six hundreds down to 0.5, so we're seeing a lot of really good options for these patients and treatment.” TS 22:09  

In this comprehensive discussion, Bryan sits down with Brad Cooper, an experienced HVAC instructor from Arkansas, and JD Kelly, a trade school graduate, to tackle one of the most pressing questions in the HVAC industry: Is trade school worth it? Rather than offering a simple yes or no answer, the trio dives deep into the nuanced factors that determine whether trade school provides real value for aspiring HVAC technicians. The conversation begins with Brad's unique perspective as both a field technician with over 20 years of experience and a current instructor who transitioned to teaching five years ago. His father's business background and the common frustration of having to "go behind people and fix stuff" motivated Brad to enter education, believing that proper training from the start could eliminate many field problems. JD brings the student perspective, having attended trade school while working full-time, which gives him insight into both the challenges and benefits of formal HVAC education. A significant portion of the discussion focuses on what to look for when evaluating trade schools. The guests emphasize that the investment in laboratory equipment and facilities often reflects the school's commitment to the program - you can tell immediately upon walking into a lab whether the institution truly prioritizes HVAC education. They stress the importance of accreditation, particularly from organizations like HVAC Excellence, which provides regular oversight and ensures schools meet industry standards. The conversation reveals that accreditation isn't just about having a certificate on the wall; it represents a school's willingness to submit to external scrutiny and maintain educational quality. The discussion also addresses the critical balance between theoretical knowledge and practical application. All three speakers agree that the most valuable trade school experiences combine classroom learning with real-world field exposure through partnerships with local contractors, apprenticeship programs, or internship opportunities. They emphasize that instructor quality matters more than having the latest equipment - a humble, field-experienced teacher who can adapt to different student skill levels and learning styles proves far more valuable than someone with extensive theoretical knowledge but limited practical experience. Topics Covered School Evaluation Criteria Laboratory equipment quality and investment levels Accreditation importance (particularly HVAC Excellence) Modern tools vs. traditional equipment balance Manufacturer partnerships and industry connections Instructor Qualifications Field experience vs. teaching credentials Importance of humility and adaptability Managing diverse skill levels in the classroom Storytelling and practical application methods Program Length and Structure Comparison of certificate programs vs. associate degrees Benefits of two-year programs for comprehensive learning Integration of on-the-job training and apprenticeships Realistic expectations for different program lengths Hands-On Learning Importance of repetition and practical experience Managing consumable materials and budget constraints Real-world equipment exposure vs. lab simulations Peer mentoring and collaborative learning approaches Student Readiness and Expectations Managing diverse student backgrounds and skill levels Realistic employer expectations for graduates The value of combining school with field experience Personal responsibility in education and continuous learning Industry Connections Importance of school-contractor partnerships Field trip opportunities and manufacturer relationships Bridging the gap between classroom and real-world application The role of apprenticeships in comprehensive training   Have a question that you want us to answer on the podcast? Submit your questions at https://www.speakpipe.com/hvacschool. Purchase your tickets or learn more about the 7th Annual HVACR Training Symposium at https://hvacrschool.com/symposium. Subscribe to our podcast on your iPhone or Android. Subscribe to our YouTube channel. Check out our handy calculators here or on the HVAC School Mobile App for Apple and Android